Wealthstreet Investment Advisors’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,495
Closed -$286K 353
2019
Q4
$286K Hold
1,495
0.03% 298
2019
Q3
$261K Hold
1,495
0.03% 296
2019
Q2
$250K Sell
1,495
-3,851
-72% -$533K 0.03% 303
2019
Q1
$783K Sell
5,346
-610
-10% -$88.4K 0.1% 168
2018
Q4
$945K Sell
5,956
-1,250
-17% -$205K 0.13% 142
2018
Q3
$1.37M Buy
7,206
+500
+7% +$91.9K 0.17% 124
2018
Q2
$1.12M Buy
6,706
+815
+14% +$131K 0.15% 139
2018
Q1
$991K Buy
5,891
+4,580
+349% +$768K 0.12% 154
2017
Q4
$214K Buy
+1,311
New +$235K 0.03% 315

Other funds holding AGN

Wealthstreet Investment Advisors's AGN Position: Q1 2020 in Review

Wealthstreet Investment Advisors sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 1,495 shares — an estimated $286K sold.

Wealthstreet Investment Advisors first reported a position in AGN in Q4 2017 and held it in 9 quarters. The position peaked at $1.37M in Q3 2018. 875 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Wealthstreet Investment Advisors reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Wealthstreet Investment Advisors sold 1,495 Allergan plc shares in Q1 2020, an estimated $286K.
  • Wealthstreet Investment Advisors first reported a position in Allergan plc in Q4 2017 and held it in 9 quarters.
  • Wealthstreet Investment Advisors's Allergan plc position peaked at $1.37M in Q3 2018.
  • 875 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Wealthstreet Investment Advisors's 13F filing for Q1 2020, filed 1 May 2020.